医疗器械行业
- (2021-07-08)
- (2021-07-08)
- (2021-07-08)
- (2021-07-08)
- (2021-07-08)
- (2021-07-07)
- (2021-07-07)
Signal Transduction and Targeted Therapy:GPR160是一个与前列腺癌相关的潜在生物标记物
(2021-07-07)- (2021-07-07)
- (2021-07-07)
- (2021-07-07)
- (2021-07-07)
- (2021-07-07)
- (2021-07-07)
- (2021-07-07)
- (2021-07-07)
- (2021-07-06)
- (2021-07-06)
- (2021-07-06)
- (2021-07-06)
- (2021-07-06)
- (2021-07-06)
- (2021-07-06)
- (2021-07-06)
- (2021-07-05)
- (2021-07-05)
- (2021-07-02)
- (2021-07-02)
- (2021-07-02)
- (2021-07-02)
- (2021-07-02)
- (2021-07-02)
- (2021-07-02)
- (2021-07-02)
- (2021-07-02)
- (2021-07-02)
- (2021-07-01)
- (2021-07-01)
- (2021-07-01)
- (2021-07-01)
- (2021-07-01)
- (2021-07-01)
- (2021-07-01)
- (2021-07-01)
- (2021-06-29)
- (2021-06-29)
- (2021-06-29)
- (2021-06-29)
- (2021-06-29)
- (2021-06-28)
- (2021-06-28)
- (2021-06-28)
- (2021-06-28)
- (2021-06-28)
- (2021-06-28)
- (2021-06-25)
- (2021-06-24)
- (2021-06-24)
- (2021-06-24)
- (2021-06-24)